Invention Grant
- Patent Title: Basal titration with adaptive target glucose level
-
Application No.: US16622326Application Date: 2018-06-08
-
Publication No.: US11298461B2Publication Date: 2022-04-12
- Inventor: Tinna Bjoerk Aradottir , Henrik Bengtsson , Morten Lind Jensen , Pete Brockmeier
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Wesley Nicolas
- Priority: EP17178877 20170629,EP17190146 20170908
- International Application: PCT/EP2018/065126 WO 20180608
- International Announcement: WO2018/228932 WO 20181220
- Main IPC: A61M5/172
- IPC: A61M5/172 ; G16H20/17 ; A61M5/142

Abstract:
Systems and methods are provided for adjusting long acting insulin medicament dosages for a subject. A plurality of timestamped glucose measurements of the subject is obtained. A titration glucose level (246) is computed as a measure of central tendency (244, 268, 274) of a titration subset of small glucose measurements (240, 269, 273) identified within the timestamped glucose measurements, wherein the measure of central tendency represents a measure of small glucose measurements for the primary time window. A long acting insulin medicament dosage (216) is adjusted or maintained based upon the obtained titration glucose level (246).
Public/Granted literature
- US20210146046A1 BASAL TITRATION WITH ADAPTIVE TARGET GLUCOSE LEVEL Public/Granted day:2021-05-20
Information query
IPC分类: